Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of Anti-CTLA4 Antibody in People With Advanced Synovial Sarcoma

This study has been terminated.
(Study discontinued due to poor accrual.)
Information provided by:
Ludwig Institute for Cancer Research Identifier:
First received: August 30, 2005
Last updated: April 4, 2007
Last verified: April 2007
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2007
  Estimated Primary Completion Date: No date given